Workshop on Osteoporosis

Venue: Radisson SAS, Paris Boulogne

Location: Paris, France

Event Date/Time: Jun 11, 2007 End Date/Time: Jun 12, 2007
Report as Spam


Presentation and discussion of the newly updated EMEA guideline: Guideline on the Evaluation of New Medicinal Products in the Treatment of Primary Osteoporosis (CPMP/EWP/552/95, Revision 2). The workshop will give you a global view of the European scientific and regulatory challenges for all interested stakeholders, such as EMEA, National Health Authorities and Pharmaceutical Industry when developing nowadays an anti-osteoporosis medicinal product. The US perspective will be also discussed to ensure an appropriate global management of osteoporosis. And finally will be explored new avenues to better face the future.
Representatives from pharmaceutical industry will run the Workshop in partnership with representatives from regulatory authorities. It will be not only an opportunity to meet delegates from other countries and discuss topics of common interest but also to interact with EU CHMP members and advisors to EMEA and FDA. The workshop will allow sharing knowledge learnt to date and will provide all attendees with the opportunity to explore important issues.


33 Avenue Edouard Vaillant